On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

NetworkNewsAudio – Fast-Growing Cannabis Industry Drives Biotech Research, Innovative Medical Therapy Development

Company: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)
Category: News

Related Editorial
The rapidly growing cannabis industry has spawned a range of diverse companies focusing on innovative technologies for cannabis cultivation, as well as the development of cannabis-based medical therapies for an array of diseases and ailments. The market has given rise to biotech companies with exciting advances in product formulation and delivery. At the cutting-edge of innovation, PreveCeutical Medical Inc. (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) (PRVCF Profile) has developed an innovative cannabidiol (CBD)-based nose-to-brain delivery system for the relief of a number of medical conditions. Another company, Lexaria Bioscience Corp. (OTC: LXRP) (LXRP Profile) has developed its own proprietary system for CBD-based therapy delivery. And with a market cap of over $3.6 billion, GW Pharmaceuticals plc (NASDAQ: GWPH) is an established giant in the cannabis biotech space developing plant-derived cannabinoid therapeutics. Canadian cultivator Canopy Growth Corp. (TSE: WEED) is an example of yet another company that could benefit from its therapeutic advances as the anticipated commercial availablity of pharmaceutical-grade cannabis products is met by greater demand.

To view the full editorial, visit http://nnw.fm/3UGib

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217